Who You’ll Meet at the 7th Genome Editing Therapeutics Summit

With an 80% Director, VP & C-Suite level audience, the 7th Genome Editing Therapeutics Summit is where senior decisions are being made.

Explore the audience advancing genome editing therapeutics and CRISPR innovation this September in Boston.

Discover who is attending the 7th Genome Editing Therapeutics Summit and meet experts working across gene therapy analytical development, genome editing, genome engineering, gene editing, and CRISPR delivery technologies

Having trouble downloading the audience preview? Let us know and we’ll email it to you instead.

Recently Registered Companies Include

Eli Lilly & Co. is attending the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
7th Genome Editing Therapeutics Summit 2026 Event Image

Explore the Agenda

See exactly which delivery, manufacturing and regulatory sessions are relevant to your genome editing program.

7th Genome Editing Therapeutics Summit 2026 Event Image

Partner With Us

Put your solutions in front of the genome editing decision-makers actively looking for them.

7th Genome Editing Therapeutics Summit 2026 Event Image

Join Genome Editing Experts

Connect with the R&D, clinical and regulatory leaders driving genome editing therapeutics forward.